CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 134 filers reported holding CYMABAY THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 1.59 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $77,000 | +1440.0% | 10,770 | +206.1% | 0.01% | – |
Q1 2020 | $5,000 | +66.7% | 3,519 | +157.0% | 0.00% | – |
Q4 2019 | $3,000 | +50.0% | 1,369 | +238.9% | 0.00% | – |
Q3 2019 | $2,000 | -85.7% | 404 | -79.7% | 0.00% | -100.0% |
Q2 2019 | $14,000 | -63.2% | 1,990 | -29.9% | 0.00% | -66.7% |
Q1 2019 | $38,000 | +660.0% | 2,839 | +307.3% | 0.00% | – |
Q4 2018 | $5,000 | – | 697 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management IV, LLC | 2,254,502 | $20,741,000 | 14.54% |
Versant Venture Management, LLC | 1,048,601 | $9,647,127,000 | 10.15% |
Abingworth LLP | 1,147,077 | $10,553,000 | 7.65% |
Omega Fund Management, LLC | 551,477 | $5,074,000 | 3.67% |
Opaleye Management Inc. | 665,000 | $6,118,000 | 1.96% |
DAFNA Capital Management LLC | 361,164 | $3,323,000 | 1.79% |
Boxer Capital, LLC | 1,012,986 | $9,319,000 | 1.70% |
Foresite Capital Management III, LLC | 600,000 | $5,520,000 | 1.55% |
NEXTHERA CAPITAL LP | 536,568 | $4,936,000 | 0.91% |
Perceptive Advisors | 2,685,882 | $24,710,000 | 0.82% |